# AptarGroup, Inc. (ATR) Stock Analysis: Discovering the 11.29% Upside Potential

- Link: https://www.directorstalkinterviews.com/aptargroup-inc-atr-stock-analysis-discovering-the-11-29-upside-potential/4121241151
- Published: 2026-02-23T11:29:52+00:00
- Author: Madison Wilson

AptarGroup, Inc. (NYSE: ATR) is a noteworthy player in the Healthcare sector, specifically
within the Medical Instruments & Supplies industry. With a market capitalization
of $9.52 billion, the company has carved out a significant niche in the drug delivery
and consumer product dispensing market. Headquartered in Crystal Lake, Illinois,
AptarGroup boasts a diversified portfolio, providing solutions for pharmaceutical,
beauty, and consumer goods markets across the globe.

#### Current Price and Market Position

As of the latest trading session, AptarGroup’s stock is priced at $145.05, reflecting
a minor price change of $1.89, or 0.01%. The stock has moved within a 52-week range
of $113.12 to $161.82, indicating a stable performance with room for growth. An 
analysis of the 50-day and 200-day moving averages, $126.71 and $137.07 respectively,
suggests a positive trend, with the current price comfortably above both averages.

#### Valuation Insights

Valuation metrics reveal a forward P/E ratio of 22.70, which positions AptarGroup
as a moderately priced stock relative to its earnings potential. However, several
valuation metrics, including the trailing P/E and PEG ratios, are not available,
making it essential for investors to rely on forward-looking projections and earnings
expectations.

#### Performance and Growth

AptarGroup has demonstrated robust revenue growth of 13.50%, signaling strong operational
performance and market demand for its products. The company also reports an EPS 
of $5.89 and an impressive return on equity of 15.10%, underscoring its profitability
and effective management practices.

The company’s free cash flow stands at approximately $205.9 million, providing a
solid foundation for continued investment in innovation and expansion. This financial
flexibility is crucial for maintaining its competitive edge in a rapidly evolving
industry.

#### Dividend and Income Potential

For income-focused investors, AptarGroup offers a modest dividend yield of 1.28%
with a payout ratio of 31.07%. This sustainable payout ratio suggests that the company
is balancing shareholder returns with reinvestment in growth opportunities.

#### Analyst Ratings and Future Outlook

AptarGroup has attracted a mix of analyst opinions, with five buy ratings and three
hold ratings, and notably, no sell ratings. This consensus reflects confidence in
the company’s future prospects. The average target price of $161.43 indicates a 
potential upside of 11.29% from the current price level, offering investors a compelling
growth opportunity.

#### Technical Analysis

Technical indicators reveal a moderately bullish sentiment, with a Relative Strength
Index (RSI) of 52.30, indicating that the stock is neither overbought nor oversold.
The MACD is at 5.26, above the signal line of 4.11, further supporting a positive
outlook for the stock’s momentum.

#### Strategic Positioning

AptarGroup’s strategic focus on innovation and diversification across its Pharma,
Beauty, and Closures segments positions it well to capitalize on emerging trends
in health and consumer markets. Its global reach, with significant operations in
Asia, Europe, Latin America, and North America, provides a broad platform for growth
and resilience against regional economic fluctuations.

Investors considering AptarGroup as a potential addition to their portfolio should
weigh its stable financial performance, growth prospects, and moderate valuation
against the backdrop of its industry dynamics and macroeconomic factors. With a 
promising upside potential, AptarGroup presents a balanced opportunity for those
seeking both growth and income in the healthcare sector.

Share on:
